Brand Study › Supplement ad machines › Cymbiotika
Premium liposomal liquid supplements in single-serve packets (glutathione, vitamin C, magnesium, sea moss, NAD+), sold by subscription mostly to women, with beauty-from-within as a core angle.


FormatLiquid packets, 26 pouches per box = 1-month supply. 12-pack starter kit also sold.
One-time$88.00 per box. 12-pack starter kit $32 on site; Target 12-packs $29.99.
Subscription$79.20 recurring (10% off). First subscription order 30% off. 'Pause, skip, or cancel anytime. Free shipping, every time.'
Other offersMore subscriptions = bigger discount: 1 item 30%, 2 items 34%, 3 items 38%, 4+ items 40% (first order). '20% off Solution Stacks' (2-product outcome bundles). Free gift unlocked at $110 cart ('Choose one of the three starter kits'). Hundred Health blood test + 1-year app for $49 (normally $199) added to a subscription. Gary Brecka protocol pages give 'an extra 30% off'.
Guarantee'60-day money-back, happiness guarantee': first product only, one per customer/household, no need to return the product; direct website orders only (not Amazon or retail). 'Exclusions apply.'
Medium-volume Meta testing built around one idea — absorption — sold through beauty and wellness outcomes; landing pages are coded by angle and funnel stage.
Top-of-funnel listicles, outcome-with-a-timeline pages, 2-product 'stack' pages and expert protocol pages, all ending in a subscription buy box.
Subscription-first with discounts that grow with the number of subscribed items, a cart gift threshold, bundles, and a partner add-on.
A tiered affiliate 'Collective', a separate UGC creator program, one big expert partner (Gary Brecka) and celebrity investors used for culture moments.
DTC first; national retail since late 2025, plus live events and an expert-podcast partner. TV exists but is not active now.
Loyalty that grows with months subscribed, heavy email automation, and churn as the main success metric.
| What | Number | Date |
|---|---|---|
| Revenue | $150M annual (late 2025)18,21 | 2025-11 / 2026-01 |
| Revenue (other report) | $200M in sales over the last 12 months23 | 2025-10 |
| Revenue expected | $200M gross in 202618 | 2026-01-28 |
| Growth | 596% revenue growth 2022–2024 (Inc. Pacific list, No. 10)24 | 2025-04-02 |
| Packets sold | 100M+ (Oct 2025); 200M+ (July 2026)19,22 | 2025-10 / 2026-07 |
| Meta ads (Motion) | 300 active; about 27 new creatives per week17 | 2026 (data refreshed ~4 months before 2026-09-30) |
| Email revenue | $13M from email in 2024; 15+ Klaviyo flows25 | 2025-02-13 |
| Affiliates | 1,200+ enrolled; 77,000+ clicks; 7,000+ conversions26 | undated case study |
| Target stores | 1,900+ (launch)23 | 2025-11 |
| AOV / retention | AOV $100+; average customer 6+ months19 | 2026-07-20 |
| Seed round | $25M led by David Grutman (first outside equity)21 | 2025-11-06 |
| Customer mix | 80% female20 | 2025-12-12 |
One mechanism sold everywhere: 'liposomal absorption' is the reason to buy in every ad, listicle and expert quote.
Outcome 'Solution Stacks' + a discount ladder for more subscriptions (30→40%) + a $110 gift threshold push AOV to $100+.
Loyalty rewards time, not spend: the discount grows the longer you stay subscribed.
Disciplined page testing: angle-coded pages (problem / authority / proof × version) and 'TOF' listicles dated in the page title.
Profile researched 2026-09-30 from the brand’s own site and product pages, company filings and press releases, founder/CMO interviews, vendor case studies and trade press — every point links to its source; agency/blog teardowns are marked as weaker; anything unconfirmed is under Open questions. Live ad count: Meta Ad Library, United States, active ads on the brand’s own page(s), counted 2026-09-30. Phone captures: iPhone-size browser, 2026-09-30. Notes: fuma-hk/research/brand-study/cymbiotika.json